Skip to main content

Molecular Surveillance and Cluster Detection Technologies: MPH Practicum Project Proposal Idea

 I recently read through the CDC's DETECTING AND RESPONDING TO HIV TRANSMISSION CLUSTERS: A GUIDE FOR HEALTH DEPARTMENTS (2018), and have more questions than answers about the nature and scope of this novel surveillance strategy, its ethical and societal implications, as well as the impact of its implementation on minorities at-risk of HIV/STI. 

Medical Monitoring Project( VDH Stakeholder Meeting: 2015)

-Ongoing supplemental surveillance system assessing behaviors and clinical characteristics of persons w/HIV who have received outpatient HIV medical care. 

-To learn more about the experiences and needs of people receiving care

-Funded by CDC

HIV Incidence Surveillance 

- Provides estimates of the number of new HIV infection over a certain period of time.

- Incidence refers to persons newly infected with HIV in a specified time period, whereas a person newly diagnosed with H IV may have been infected for years before diagnosed. 

Molecular HIV Surveillance

-Collect all HIV nucleotide sequence data from laboratories that perform HIV genotypic drug resistance testing; 

- What regulations need to be changed to facilitate full implementation of this project?

- Assess HIV drug resistance, evaluate HIV genetic diversity, and describe HIV transmission patterns.



Molecular HIV Surveillance

Surveillance staff examine how closely related different viruses are based on the similarities and differences between the DNA sequence patterns. When combined with information on a person’s demographics, geographic location, and risk characteristics, this analysis can help describe likely transmission patterns between persons. There is much debate about whether clear directionality can be determined. Analysis of these transmission patterns or networks can help guide HIV prevention efforts and optimize the allocation of resources by identifying persons at highest risk of being infected with HIV. Identifying active HIV transmission is key in HIV prevention and care efforts. It is important to identify growing clusters in order interrupt transmission.


Hypothesis:  Expanding partner services to include genetic as well as named partners has potential to slow cluster growth and ultimately to slow incidence. - Inquire about this in the context of the Code of Virginia




Evaluation:

How to Evaluate Our Work
Did cluster growth slow or stop?
Are the new positives seen in the cluster prevalent or incident positives?
– Good outcome: more prevalent cases were diagnosed and/or genotyped, and thus there is more complete mapping of clusters
– Bad outcome: more incident cases, new AHI
Were OOC persons successfully returned
to care?
Did viremic persons achieve suppression?

■  What is the cluster’s history of growth, and what growth phase (geometric, exponential) is it in 
at present?   It is on the way up or is it flat, spent?
■  How many persons in this cluster are currently viremic, and what positions do they occupy in the 
cluster (central, peripheral, bridging)?
■  How many new acute HIV infections are in the cluster and what positions do they hold?
■  What variables and statistics best predict forward growth?
■  What other factors should be considered -- geography, risk factor, age, race/ethnicity?





















Comments

Popular posts from this blog

Community Practicum Project: Part 1-3

As a scholar with specific subject matter expertise in anthropology and public health, and as an individual living with HIV, a first generation college student, and queer man with history of substance abuse whose work and life are deeply intertwined, I have derived a lot of comfort and hope in bearing witness to the power of community coalitions while accompanying community leaders and advocates in mobilizing to take care of one another, to act, and to engage in necessary fights around issues that have long been in existence: universal and meaningful healthcare, abolition, housing rights, equal employment, gender equality, environmental justice, and rights of marginalized communities, displaced populations, migrants and immigrants. I have worked alongside community leaders, activists, and health and social providers in the field of HIV and disease prevention who have long refused to accept the status quo, and have instead, created their own forms of care or reimagined the existing sy

The War on Sex: Some Notes

  The War on Sex Sex is an important site of social control, adjudication, and- ultimately -oppression. Many social movement organizations have focused on sexual health and do not generally frame their work in terms of social justice or civil rights. The failed attempts to decriminalize HIV in the Virginia legislature, both within and outside the General Assembly, are both troubling and deserving of critical examination, and yet they are just pieces of a much larger puzzle comprising legal, social, and economic systems that do not readily seem to fit together. Institutional ethnography: Interrelationships among the General Assembly, Virginia Department of Health, and community organizations working to repeal the laws criminalizing HIV in the Commonwealth are each a subject of analysis here… The Problems of Prospective: “Thinking Sex”                 From the beginning, this issue was not seen for what it truly was and is: a war on sex.                 By only problematizin

The Economic Burden of AIDS in America: Increasing Access to HIV Medicines

The Economic Burden of AIDS in America: Increasing Access to HIV Medicines Clay Porter Eastern Virginia Medical School Abstract This paper examines the cost of the HIV epidemic in America and surmises the economic benefits of an early targeted roll out of treatment for minority communities. By assessing the literature on health disparities in accessing HIV/AIDS medicines and the financial toll of medical costs associated with HIV-related complications, it is determined that increased access will reduce the economic burden of the virus on both at risk communities and the health services systems they rely on. The Economic Burden of AIDS in America: Increasing Access to HIV Medicines There are an estimated 1.1 million individuals living with human immunodeficiency virus (HIV) infection in the United States, and about 66% of this population are not engaged in medical care (CDC, 2014). This disparity is extreme, with black and Hispanic communities, specifical